Shafique Virani serves as Executive at RECURSION PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Shafique Virani has executed 60 insider transactions totaling $4.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 16, 2022 involved selling 30,000 shares valued at $378.3K.
Shafique Virani currently holds 136,748 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shafique Virani has been a net seller of RXRX stock. They have purchased $0 and sold $4.2M worth of shares.
Shafique Virani's most recent insider trade was on Aug 16, 2022, when they sold 30,000 shares at $12.61 per share.
Get notified when new Form 4 filings are submitted
| $2.22 |
| Discretionary |
| Aug 15, 2022 | RXRX | $7.9K | Payment | 613 | $12.96 | Discretionary |
| May 16, 2022 | RXRX | $4.9K | Payment | 870 | $5.67 | Discretionary |
| Feb 4, 2022 | RXRX | $0 | Award | 40,225 | $N/A | Discretionary |
| Feb 4, 2022 | RXRX | $12.7K | Payment | 1,114 | $11.40 | Discretionary |
| Feb 4, 2022 | RXRX | $0 | Award | 2,718 | $N/A | Discretionary |
| Jun 2, 2021 | RXRX | $100.0K | Option Exercise | 45,045 | $2.22 | Discretionary |
| Apr 20, 2021 | RXRX | $0 | Other | 18,000 | $N/A | Discretionary |
| Apr 20, 2021 | RXRX | $0 | Other | 18,000 | $N/A | Discretionary |